Elotuzumab Enhances CD16‐Independent NK Cell‐Mediated Cytotoxicity against Myeloma Cells by Upregulating Several NK Cell‐Enhancing Genes

Yan-Hua Wang(Tokyo Women's Medical University), Junji Tanaka(Toho University)
Journal of Immunology Research
January 1, 2024
Cited by 8


Related Papers